Comprehensive Stress Stability Studies Reveal the Prominent Stability of the Liquid-Formulated Biotherapeutic Asymmetric Monovalent Bispecific IgG1 Monoclonal Antibody Format.

The developed asymmetric monovalent bispecific IgG1 or Duet monoclonal antibody (Duet mAb) has two distinct fragment antigen-binding region (Fab) subunits that target two different epitope specificities sequentially or simultaneously. The design features include unique engineered disulfide bridges, knob-into-hole mutations, and kappa and lambda chains to produce Duet mAbs. These make it structurally and functionally complex, so one expects challenging developability linked to instability, degradation of products and pathways, and limited reports available. Here, we have treated the product with different sources of extreme stress over a lengthy period, including varying heat, pH, photo stress, chemical oxidative stress, accelerated stress in physiological conditions, and forced glycation conditions. The effects of different stress conditions on the product were assessed using various analytical characterization tools to measure product-related substances, post-translational modifications (PTMs), structural integrity, higher-order disulfide linkages, and biological activity. The results revealed degradation products and pathways of Duet mAb. A moderate increase in size, charge, and hydrophobic variants, PTMs, including deamidation, oxidation, isomerization, and glycation were observed, with most conditions exhibiting biological activity. In addition, the characterization of fractionated charge variants, including deamidated species, showed satisfactory biological activity. This study demonstrated the prominent stability of the Duet mAb format comparable to most marketed mAbs.

Identification and quantification of chain-pairing variants or mispaired species of asymmetric monovalent bispecific IgG1 monoclonal antibody format using reverse-phase polyphenyl chromatography coupled electrospray ionization mass spectrometry.

Developing a knob-into-hole asymmetric bispecific IgG1 monoclonal antibody (mAb) poses manufacturing challenges due to the expression of chain pairing variants, also called mispaired species, in the desired product. The incorrect pairing of light and heavy chains could result in heterogeneous mispaired species of homodimers, heterodimers, light chain swapping, and low molecular weight species (LMWS). Standard chromatography, capillary electrophoretic, or spectroscopic methods poorly resolve these from the main variants. Here, we report a highly sensitive reverse-phase polyphenyl ultra-high-performance liquid chromatography (RP-UHPLC) method to accurately measure mispaired species of Duet mAb format, an asymmetric IgG1 bispecific mAb, for both process development and quality control analytical tests. Coupled with electrospray ionization mass spectrometry (ESI-MS), it enabled direct online characterization of mispaired species. This single direct assay detected diverse mispaired IgG-like species and LMWS. The method resolved eight disulfide bonds dissociated LMWS and three mispaired LMWS. It also resolved three different types of IgG-like mispaired species, including two homodimers and one heterodimer. The characterization and quantification simultaneously enabled the cell line selection that produces a lesser heterogeneity and lower levels of mispaired species with the desired correctly paired product. The biological activity assessment of samples with increased levels of these species quantified by the method exhibited a linear decline in potency with increasing levels of mispaired species in the desired product. We also demonstrated the utility of the technique for testing in-process intermediate materials to determine and assess downstream purification process capability in removing diverse mispaired IgG-like species and LMWS to a certain level during the downstream purification process. Our investigation demonstrates that adopting this method was vital in developing asymmetric bispecific mAb from the initial stage of cell line development to manufacturing process development. Therefore, this tool could be used in the control strategy to monitor and control mispaired species during manufacturing, thus improving the quality control of the final product.

Lingular pneumonia obscured by implanted cardioverter-defibrillator: Lateral thinking.

A 56-year-old female with an implanted cardioverter-defibrillator was admitted with a short history suggestive of a diagnosis of pneumonia. An AP radiograph did not identify an area of consolidation. A subsequent lateral radiograph highlighted an extensive left-lingular-lobe consolidation that had been obscured by the cardiac device. This case highlights the fact that large devices can obscure significant pathology, and that lateral or cross-sectional imaging may be helpful in reaching a diagnosis.

Experimental and theoretical studies of quadrupolar oligothiophene-cored chromophores containing dimesitylboryl moieties as π-accepting end-groups: syntheses, structures, fluorescence, and one- and two-photon absorption.

Quadrupolar oligothiophene chromophores composed of four to five thiophene rings with two terminal (E)-dimesitylborylvinyl groups (4 V-5 V), and five thiophene rings with two terminal aryldimesitylboryl groups (5 B), as well as an analogue of 5 V with a central EDOT ring (5 VE), have been synthesized via Pd-catalyzed cross-coupling reactions in high yields (66-89%). Crystal structures of 4 V, 5 B, bithiophene 2 V, and five thiophene-derived intermediates are reported. Chromophores 4 V, 5 V, 5 B and 5 VE have photoluminescence quantum yields of 0.26-0.29, which are higher than those of the shorter analogues 1 V-3 V (0.01-0.20), and short fluorescence lifetimes (0.50-1.05 ns). Two-photon absorption (TPA) spectra have been measured for 2 V-5 V, 5 B and 5 VE in the range 750-920 nm. The measured TPA cross-sections for the series 2 V-5 V increase steadily with length up to a maximum of 1930 GM. We compare the TPA properties of 2 V-5 V with the related compounds 5 B and 5 VE, giving insight into the structure-property relationship for this class of chromophore. DFT and TD-DFT results, including calculated TPA spectra, complement the experimental findings and contribute to their interpretation. A comparison to other related thiophene and dimesitylboryl compounds indicates that our design strategy is promising for the synthesis of efficient dyes for two-photon-excited fluorescence applications.

A combined experimental and computational study of fluxional processes in sigma amine-borane complexes of rhodium and iridium.

A combined experimental and computational study on the fluxional processes involving the M-H and B-H positions in the sigma amine-borane complexes [M(PR3)2(H)2(η(2)-H3B·NMe3)][BAr(F)4] (M = Rh, Ir; R = Cy for experiment; R = Me, Cy for computation; Ar(F) = 3,5-(CF3)2C6H3) is reported. The processes studied are: B-H bridging/terminal exchange; reaction with exogenous D2 leading to exchange at M-H; and intramolecular M-H/B-H exchange. Experimentally it was found that B-H bridging/terminal exchange is most accessible and slightly favoured for Rh; D2/M-H exchange occurs at qualitatively similar rates for both M = Rh and Ir, while M-H/B-H exchange is the slowest overall, with the Ir congener having a lower barrier than Rh. Evidence for the isotopic perturbation of equilibrium is also reported for the BH/BD isotopologues of [Ir(PCy3)2(H)2(η(2)-H3B·NMe3)][BAr(F)4]. DFT calculations using model complexes (R = Me) qualitatively reproduce the relative rates of the various exchange processes for both M = Rh and Ir, i.e. barriers for B-H bridging/terminal exchange are less than those for M-H/H2 exchange, which in turn are less than those for M-H/B-H exchange. Which metal promotes these processes more effectively depends upon the nature of the rate-limiting transition state, which can change between Rh and Ir. Computational analysis of the full experimental system (R = Cy) reveals similar overall trends in terms of the relative ease of the various exchange processes. However, there are differences in the details, and these are discussed.

Dehydrocoupling of dimethylamine borane catalyzed by Rh(PCy3)2H2Cl.

The Rh(III) species Rh(PCy3)2H2Cl is an effective catalyst (2 mol %, 298 K) for the dehydrogenation of H3B·NMe2H (0.072 M in 1,2-F2C6H4 solvent) to ultimately afford the dimeric aminoborane [H2BNMe2]2. Mechanistic studies on the early stages in the consumption of H3B·NMe2H, using initial rate and H/D exchange experiments, indicate possible dehydrogenation mechanisms that invoke turnover-limiting N-H activation, which either precedes or follows B-H activation, to form H2B═NMe2, which then dimerizes to give [H2BNMe2]2. An additional detail is that the active catalyst Rh(PCy3)2H2Cl is in rapid equilibrium with an inactive dimeric species, [Rh(PCy3)H2Cl]2. The reaction of Rh(PCy3)2H2Cl with [Rh(PCy3)H2(H2)2][BAr(F)4] forms the halide-bridged adduct [Rh(PCy3)2H2(µ-Cl)H2(PCy3)2Rh][BAr(F)4] (Ar(F) = 3,5-(CF3)2C6H3), which has been crystallographically characterized. This dinuclear cation dissociates on addition of H3B·NMe2H to re-form Rh(PCy3)2H2Cl and generate [Rh(PCy3)2H2(η(2)-H3B·NMe2H)][BAr(F)4]. The fate of the catalyst at low catalyst loadings (0.5 mol %) is also addressed, with the formation of an inactive borohydride species, Rh(PCy3)2H2(η(2)-H2BH2), observed. On addition of H3B·NMe2H to Ir(PCy3)2H2Cl, the Ir congener Ir(PCy3)2H2(η(2)-H2BH2) is formed, with concomitant generation of the salt [H2B(NMe2H)2]Cl.

Development of a generic mechanism for the dehydrocoupling of amine-boranes: a stoichiometric, catalytic, and kinetic study of H3B·NMe2H using the [Rh(PCy3)2]+ fragment.

The multistage Rh-catalyzed dehydrocoupling of the secondary amine-borane H(3)B·NMe(2)H, to give the cyclic amino-borane [H(2)BNMe(2)](2), has been explored using catalysts based upon cationic [Rh(PCy(3))(2)](+) (Cy = cyclo-C(6)H(11)). These were systematically investigated (NMR/MS), under both stoichiometric and catalytic regimes, with the resulting mechanistic proposals for parallel catalysis and autocatalysis evaluated by kinetic simulation. These studies demonstrate a rich and complex mechanistic landscape that involves dehydrogenation of H(3)B·NMe(2)H to give the amino-borane H(2)B═NMe(2), dimerization of this to give the final product, formation of the linear diborazane H(3)B·NMe(2)BH(2)·NMe(2)H as an intermediate, and its consumption by both B-N bond cleavage and dehydrocyclization. Subtleties of the system include the following: the product [H(2)BNMe(2)](2) is a modifier in catalysis and acts in an autocatalytic role; there is a parallel, neutral catalyst present in low but constant concentration, suggested to be Rh(PCy(3))(2)H(2)Cl; the dimerization of H(2)B═NMe(2) can be accelerated by MeCN; and complementary nonclassical BH···HN interactions are likely to play a role in lowering barriers to many of the processes occurring at the metal center. These observations lead to a generic mechanistic scheme that can be readily tailored for application to many of the transition-metal and main-group systems that catalyze the dehydrocoupling of H(3)B·NMe(2)H.

Catching the first oligomerization event in the catalytic formation of polyaminoboranes: H3B·NMeHBH2·NMeH2 bound to iridium.

We report the first insertion step at a metal center for the catalytic dehydropolymerization of H(3)B·NMeH(2) to form the simplest oligomeric species, H(3)B·NMeHBH(2)·NMeH(2), by the addition of 1 equiv of H(3)B·NMeH(2) to [Ir(PCy(3))(2)(H)(2)(η(2)-H(3)B·NMeH(2))][BAr(F)(4)] to give [Ir(PCy(3))(2)(H)(2)(η(2)-H(3)B·NMeHBH(2)·NMeH(2))][BAr(F)(4)]. This reaction is also catalytic for the formation of the free linear diborazane, but this is best obtained by an alternative stoichiometric synthesis.

Hydroboration of an alkene by amine-boranes catalysed by a [Rh(PR3)2]+ fragment. Mechanistic insight and tandem hydroboration/dehydrogenation.

The catalytic hydroboration of tert-butylethene using H(3)B·NMe(3) gives RH(2)B·NMe(3). With H(3)B·NMe(2)H tandem hydroboration under mild conditions/dehydrocoupling occurs that produces R(2)B=NMe(2) (R = H, CH(2)CH(2)(t)Bu).

Reversible C-H activation of a P(t)Bu(i)Bu2 ligand to reveal a masked 12 electron [Rh(PR3)2]+ cation.

[Rh(P(t)Bu(i)Bu(2))(2)][BAr(F)(4)], formed by removal of H(2) from [RhH(2)(P(t)Bu(i)Bu(2))(2)][BAr(F)(4)], is in rapid equilibrium between C-H activated Rh(III) isomers, but reacts as a masked 12-electron [Rh(P(t)Bu(i)Bu(2))(2)](+) Rh(I) cation.